| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058392 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors |
| 03/16/2006 | US20060058338 [1,7]naphthyridines as pde4 inhibitors |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058284 Compounds such as tert-butyl 3-(3,4-dichlorophenyl)-3-[3-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)propyl]pyrrolidine-1-carboxylate;useful in the inhibition of HIV replication, therapy and prophylaxis of an HIV infection, and in therapy of the resulting acquired immune deficiency syndrome (AIDS) |
| 03/16/2006 | US20060058279 Topical compositions comprising ascomycins |
| 03/16/2006 | US20060058246 Macrolide compounds endowed with antiinflammatory activity |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | CA2579547A1 Novel peptides and methods for the treatment of inflammatory disease |
| 03/16/2006 | CA2579540A1 The treatment of inflammatory disorders and pain |
| 03/16/2006 | CA2579302A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | CA2578933A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | CA2577861A1 Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/16/2006 | CA2565235A1 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634873A1 Sigma receptor inhibitors |
| 03/15/2006 | EP1634872A1 Pyrazole derivatives as sigma receptor inhibitors |
| 03/15/2006 | EP1634599A1 Iimmune stimulatory infant nutrition |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633758A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 03/15/2006 | EP1633744A1 Sulptionamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633702A1 Protease inhibitors |
| 03/15/2006 | EP1633401A1 A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 03/15/2006 | EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 03/15/2006 | EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633342A2 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 03/15/2006 | EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1509530B1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1318819A4 Treatment of trauma, and other indications |
| 03/15/2006 | EP1309593B1 Substituted pyrazoles |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1121600B1 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 03/15/2006 | EP1117356B1 Apparatus for improved administration of fentanyl and sufentanil |
| 03/15/2006 | EP1068315B1 Therapeutic agent for ngf |
| 03/15/2006 | EP1063885B1 Xylitol compositions for treating upper respiratory conditions |
| 03/15/2006 | EP1028710A4 Topical compositions for nsai drug delivery |
| 03/15/2006 | EP0934292B1 Metalloproteinase inhibitors |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0733069B1 Purified primate ctla-8 antigens and related reagents |
| 03/15/2006 | CN1747740A Analgesic composition |
| 03/15/2006 | CN1747731A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 03/15/2006 | CN1747719A Topical compositions and methods for treating pain |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1745838A Rheumatism curing compound Chinese medicine |
| 03/15/2006 | CN1745833A Iron bar spray of Tibetan medicine |
| 03/15/2006 | CN1745807A Tablet for treating difficult menstruation and its preparation |
| 03/15/2006 | CN1745802A Plaster for treating pain and prpearation thereof |
| 03/15/2006 | CN1745799A Huoxiang Zhengqi drop pill an dits preparation |
| 03/15/2006 | CN1745778A Chinese medicine infusion granule for treating appendicitis |
| 03/15/2006 | CN1745766A Plaster for treating injury and fracture |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245382C 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245209C External used Chinese medicine for pain stopping |
| 03/15/2006 | CN1245208C Cold dispelling and pain alleviating liquid and its preparation |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245191C Pelvic inflammation-treating traditional Chinese medicinal preparation |
| 03/14/2006 | US7012138 Chiral polysaccharide esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or for chiral chromatography |
| 03/14/2006 | US7012135 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012096 Comprising a weak organic acid such as acetic acid, vinegar, and/or citric acid dispersed within a carrier, at acidic pH, for treating burns; provides local analgesia |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/14/2006 | US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases |